Breast Cancer - Block 4 Flashcards

(37 cards)

1
Q

What are the RF of breast cancer?

A
  1. Female
  2. Current hormone therapy
  3. Increasing age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the screening recommendation of ACS?

A

Breast self-exam: ≥20 YO optional
Clinical breast exam: N/A
Mammogram: 40-44 (optional annually)
* ≥55 YO Q2Y

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the screening for USPTF?

A

Breast self-exam: Not recommended
Clinical breast exam: N/A
Mammogram: 40-50 (optional)
* 50-74 YO: Q2Y

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the screening recommnedations of NCCN?

A

Breast self-exam: ≥25 breast awareness
Clinical breast exam: 25-39 YO Q1-3Y
Mammogram: ≥40 Y annually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do you diagnose of breast cancer?

A
  1. Mammogram
  2. MRI if dense tissue
  3. Biopsy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the stages of breast cancer?

A

0: carcinoma in situ
1: Small and confined to breast
2: large tumor and/or local lymph node involvement
3: Tumor any size or direct extension into chest wall with more extensive lymph node involvement
4: metastases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the prognostic factors of breast cancer?

A
  1. Number of affected lymph nodes (most important)
  2. Age <35 YO
  3. Ethnicity: AA are more at risk
  4. Estrogen receptor/Progesterone receptor (ER/PR) Status (most favorable prognosis)
  5. HER-2/neu oncogene (most aggressive)
  6. Anti-HER2 therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tx modalities for breast cancer?

A
  1. Surgery
  2. Neoadj
  3. Systemic adj (chemo and endocrine therapy)
  4. Radiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the surgical options for breast cancer?

A
  1. Modified radical mastectomy
  2. Breast conserving therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Outline the modifiedradical mastectomy?

A

Removal of entire breast to maintain ROM and strengh
* Recommend for those with BRCA 1 o 2 mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Outline and indications of BCT therapy?

A

Must follow with radiation (3-5 wks) due to higher risk for local recurrance
Indication: must meet lumpectomy criteria (<5cm, no h/o radiation to the chest, only in one quadrant, positive margins, not pregnant or very early)
* Neoadjuvnt therapy is required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When is sentinel lymph node biopsy indicated?

A

Identified with radiologic dye
Preferred for stage 1-2

  • Reduces problems from lymph node the dissection such as lymphedema, sensory loss, pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the RF of lymphedema?

A
  1. Extent of axillary surgery
  2. Axilliary radiation
  3. Infection
  4. Obesity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are adj options?

A
  1. Hormone
  2. Chemo
  3. Radiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Factors you need to consider for adjuvant therapy?

A
  1. ER/PR status
  2. HER2 status
  3. Menopause status
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the tx option for tumors >1 cm or + lymph nodes?

17
Q

What are the preferred adj regimens for HER2- Stage 1-2?

A
  1. Dose dense AC followed by weekly paclitaxel
  2. Dose dense AC followed by q2week paclitaxel
  3. Doxetaxel, cyclophosphamide (TC)

AC: doxorubicin/cyclophosphamide

18
Q

What are the preferred adj regimens for HER2+ Stage 1-2?

A
  1. AC followed by paclitaxel + trastuzumab
  2. AC followed by paclitaxel + trastuzumab ± pertuzumab
  3. Docetaxel, carboplatin, trastuzumab (TCH) ± pertuzumab

AC: doxorubicin/cyclophosphamide

19
Q

What are the HER2 + tx options?

A
  1. Trastuzumab
  2. Pertuzumab
20
Q

How do you dose trastuzumab? ADRs?

A

Don’t administer with antracyclines
* Hypersensitivity >12hrs after admin

ADR: arthralgias, cardiac tox, infusion related rx

21
Q

Monitoring and ADRs of pertuzumab?

A

Monitoring: LVEF
ADRs: diarrhea, N, alopecia, PN, LV dysfunction, infusion rx

22
Q

Indications for adj endocrine therapy?

A
  1. Estrogen receptor
  2. Pregesterone receptor
  3. Cancer cells can have 1 receptor or both
23
Q

Types of adjuvant endocrine tx?

A
  1. Ovarian ablation
  2. Use of LH-RH agonists
  3. Use of aromatase inhibitors
  4. Use of SERM

Tx is based on pre/post menopausal

24
Q

What are is the adj endocrin tx for premenopausal?

25
What are is the adj endocrin tx for postmenopausal?
26
Antiestrogen types?
1. Tamoxifen 2. Fulvestrant
27
ADRs and CP of tamoxifen?
**ADR:** VTE and uterine cancer **CP:** DDI with paroxetine or fluoxetine * CYP2D6 interaction decreases tomoxifen efficacy
28
ADR and CP of fulvestrant?
**ADR:** VTE and increased LFTs **CP:** used for progression only, no initial tx
29
What are types of aromatase inhibitors?
1. Anastrozol 2. Letrozole 3. Exemestane
30
ADR and CP of aromatase inhibitors?
**ADR:** Arthralgias, decreased bone density, increased risk of fracture **CP:** Supplemental calcium and vit D, may increase cholesterol
31
Overall tx outline for adjuvant endocrine tx?
32
Tx options for metastatic breast cancer?
1. Surgery (supportive care) 2. Radiation 3. Endocrine therapy 4. HER2 targeted 5. Chemo
33
Metastatic tx for pre menopausal?
**If no endocrine tx within 1 year:** * 1st line tx is tamoxifen OR * Ovarian suppression **If pt received endocrine tx within last year:** * Ovarian ablation/suppression with systemic therapy
34
Metastatic tx for post menopausal?
AI + fulvestrant OR AI + palbociclib
35
What are preferred agents for metastatic chemo?
1. Capcetibine 2. Doxorubicin 3. Gemcitabine 4. Vinorelbine 5. Paclitaxel
36
Preferred agents for metastatic HER2 +?
1. Pertuzumab, trastuzumab, docetaxel 1. Pertuzumab, trastuzumab, paclitaxel
37
Indications for radiation?
1. After chemo 2. After surgery 3. Neoadj 4. Local recurrance 5. Palliative